• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A Novel Combination of BroadBand Light (BBL® HERO) and Nonablative Fractionated 1,927nm (MOXI) Laser for Addressing Solar Lentigines.用于治疗日光性雀斑的宽带光（BBL® HERO）与非剥脱性1,927纳米（MOXI）激光的新型联合疗法
J Clin Aesthet Dermatol. 2024 Sep-Oct;17(9-10 Suppl 1):S36-S39.
2
Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.研究分段式 1927nm 激光治疗弥漫性色素沉着异常和光化性改变的疗效。
Lasers Surg Med. 2023 Apr;55(4):344-358. doi: 10.1002/lsm.23653. Epub 2023 Mar 23.
3
Comparison of Q-switched Nd: YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asians.调Q开关钕：钇铝石榴石激光与超脉冲二氧化碳激光治疗亚洲人日光性雀斑的比较。
Lasers Surg Med. 2016 Apr;48(4):354-9. doi: 10.1002/lsm.22472. Epub 2016 Jan 12.
4
Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser.使用新型双波长和双脉冲宽度皮秒激光去除亚洲人日光性雀斑样痣的前瞻性研究。
Lasers Surg Med. 2018 Oct;50(8):851-858. doi: 10.1002/lsm.22820. Epub 2018 Apr 2.
5
The clinical and electron microscopic evaluation of the impact of pulsed dye laser techniques on solar lentigines (randomized clinical trial).脉冲染料激光技术治疗日晒斑的临床和电子显微镜评估（随机临床试验）。
J Dermatolog Treat. 2022 Feb;33(1):361-368. doi: 10.1080/09546634.2020.1755415. Epub 2020 Apr 29.
6
Clinical improvement of solar lentigines and ephelides with an intense pulsed light source.强脉冲光源治疗日光性雀斑和雀斑样痣的临床改善情况。
Dermatol Surg. 2002 Jun;28(6):504-8. doi: 10.1046/j.1524-4725.2002.01175.x.
7
A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser plus Er:YAG micropeel (combined therapy) versus Q-switched Nd:YAG alone in light solar lentigines in Asians.一项关于调Q Nd:YAG激光联合Er:YAG微剥脱术（联合治疗）与单纯调Q Nd:YAG激光对亚洲人轻度日光性雀斑早期疗效的半脸、评估者盲法随机研究。
Lasers Med Sci. 2014 May;29(3):1153-8. doi: 10.1007/s10103-013-1489-9. Epub 2013 Nov 29.
8
A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser versus Er:YAG micropeel in light solar lentigines in Asians.一项关于调Q Nd:YAG激光与铒激光微剥脱术对亚洲人轻度日光性雀斑早期疗效的半脸、评估者盲法随机研究。
J Cosmet Laser Ther. 2014 Apr;16(2):83-8. doi: 10.3109/14764172.2013.877749. Epub 2014 Feb 10.
9
Effects of topical application of B-Resorcinol and Glycyrrhetinic acid monotherapy and in combination with fractional CO laser treatment for benign hand hyperpigmentation treatment.局部应用间苯二酚和甘草次酸单药治疗以及联合分次二氧化碳激光治疗对手部良性色素沉着的影响。
J Cosmet Dermatol. 2016 Dec;15(4):413-419. doi: 10.1111/jocd.12241. Epub 2016 Jun 21.
10
Novel Low Fluence Combination Laser Treatment of Solar Lentigines in Type III Asian Skin.新型低能量联合激光治疗Ⅲ型亚洲皮肤日光性雀斑样痣
J Cutan Aesthet Surg. 2015 Oct-Dec;8(4):230-2. doi: 10.4103/0974-2077.172199.

本文引用的文献

1
Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.研究分段式 1927nm 激光治疗弥漫性色素沉着异常和光化性改变的疗效。
Lasers Surg Med. 2023 Apr;55(4):344-358. doi: 10.1002/lsm.23653. Epub 2023 Mar 23.
2
Morphological and transcriptional evaluation of multiple facial cutaneous hyperpigmented spots.多个面部皮肤色素沉着斑的形态学和转录评估
Skin Health Dis. 2022 Feb 4;2(2):e96. doi: 10.1002/ski2.96. eCollection 2022 Jun.
3
Photoprotection for Skin of Color.肤色皮肤的光保护。
Am J Clin Dermatol. 2022 Mar;23(2):195-205. doi: 10.1007/s40257-021-00670-z. Epub 2022 Jan 19.
4
Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology.激光治疗色素沉着性病变：欧洲激光皮肤科学会立场声明。
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):987-1005. doi: 10.1111/jdv.15497. Epub 2019 Mar 14.
5
Keratinocytic Malfunction as a Trigger for the Development of Solar Lentigines.角质形成细胞功能障碍作为日光性雀斑发展的触发因素。
Dermatopathology (Basel). 2019 Jan 3;6(1):1-11. doi: 10.1159/000495404. eCollection 2019 Jan-Mar.
6
Pigmentation Disorders: Diagnosis and Management.色素障碍性疾病：诊断与管理。
Am Fam Physician. 2017 Dec 15;96(12):797-804.
7
Histologic analyses on the response of the skin to 1,927-nm fractional thulium fiber laser treatment.皮肤对1927纳米掺铥光纤点阵激光治疗反应的组织学分析。
J Cosmet Laser Ther. 2018 Feb;20(1):12-16. doi: 10.1080/14764172.2017.1358455. Epub 2017 Sep 20.
8
Molecular and histological characterization of age spots.老年斑的分子与组织学特征
Exp Dermatol. 2017 Mar;26(3):242-248. doi: 10.1111/exd.13203. Epub 2017 Feb 9.
9
The Effect of MCP-1/CCR2 on the Proliferation and Senescence of Epidermal Constituent Cells in Solar Lentigo.MCP-1/CCR2对日光性雀斑样痣中表皮组成细胞增殖和衰老的影响
Int J Mol Sci. 2016 Jun 15;17(6):948. doi: 10.3390/ijms17060948.
10
Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI.激光和基于光的疗法在有色人种皮肤中的应用：Fitzpatrick 皮肤类型 V 和 VI 的治疗选择和建议。
Br J Dermatol. 2013 Oct;169 Suppl 3:91-7. doi: 10.1111/bjd.12526.

用于治疗日光性雀斑的宽带光（BBL® HERO）与非剥脱性1,927纳米（MOXI）激光的新型联合疗法

A Novel Combination of BroadBand Light (BBL® HERO) and Nonablative Fractionated 1,927nm (MOXI) Laser for Addressing Solar Lentigines.

作者信息

Hennessey Erin

机构信息

Ms. Hennessey is the Owner of Blush Aesthetics in Perrysburg and Toledo, Ohio, and Assistant Professor, Nursing, Gonzaga University in Spokane, Washington.

出版信息

J Clin Aesthet Dermatol. 2024 Sep-Oct;17(9-10 Suppl 1):S36-S39.

PMID:39386001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460752/
Abstract

Solar lentigo is a common condition that can affect people of all ages and ethnicities. The effectiveness of combining laser and light-based modalities for reducing solar lentigines was evaluated. Patients received treatment for facial solar lentigines with an advanced pulsed light device (BBL® HERO) followed by nonablative fractionated 1,927nm laser (MOXI) in a single session. Nonmalignant solar lentigines were evaluated through assessment of photographs and VISIA scans taken before and after treatment. Nine patients aged 29 to 64 years were included in this report. Across all nine patients, there was a significant increase in percentile for brown spots on VISIA scans post-treatment. Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this report demonstrate that combining BBL HERO and MOXI is effective for reducing solar lentigines.

摘要

日光性雀斑是一种常见病症，可影响所有年龄和种族的人群。评估了联合使用激光和光基治疗方式减少日光性雀斑的效果。患者在单次治疗中先用先进的脉冲光设备（BBL® HERO）对面部日光性雀斑进行治疗，随后使用非剥脱性分次1927纳米激光（MOXI）。通过评估治疗前后拍摄的照片和VISIA扫描来评估非恶性日光性雀斑。本报告纳入了9名年龄在29至64岁之间的患者。在所有9名患者中，治疗后VISIA扫描上褐色斑点的百分位数显著增加。随访时间各不相同；在一名患者中，治疗后近20个月观察到色素沉着明显减轻。本报告中的结果表明，联合使用BBL HERO和MOXI对减少日光性雀斑有效。